Literature DB >> 12117262

Concentration of selenium in the whole blood and the thyroid tissue of patients with various thyroid diseases.

M Kucharzewski1, J Braziewicz, U Majewska, S Góźdź.   

Abstract

We investigated the possible differences between the concentrations of selenium in the whole blood and thyroid tissue of patients with thyroid disease. The study comprises 41 women with nodular goiter, 19 women and 2 men with thyroid cancer, 18 women with Graves' disease, and 7 women with thyroiditis. The concentration of selenium was determined by the TRXRF method. The lowest mean selenium level was achieved in the whole blood of women with Graves' disease and the highest in the whole blood of healthy people. In the thyroid cancer tissue, we found the lowest concentration of selenium and the highest in the thyroid gland of women with nodular goiter and Graves' disease. The low selenium levels in the thyroid tissue may increase thyroid cancer risk.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12117262     DOI: 10.1385/BTER:88:1:25

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  10 in total

Review 1.  Selenium, selenoproteins and the thyroid gland: interactions in health and disease.

Authors:  Lutz Schomburg
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

Review 2.  The aging kidney and the nephrotoxic effects of mercury.

Authors:  Christy C Bridges; Rudolfs K Zalups
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2017-02-07       Impact factor: 6.393

Review 3.  Selenium Supplementation in Pregnant Women with Autoimmune Thyroiditis: A Practical Approach.

Authors:  Marianna Minnetti; Valentina Sada; Tiziana Feola; Elisa Giannetta; Carlotta Pozza; Daniele Gianfrilli; Andrea M Isidori; Alessia Cozzolino
Journal:  Nutrients       Date:  2022-05-27       Impact factor: 6.706

4.  A pilot study of serum selenium, vitamin D, and thyrotropin concentrations in patients with thyroid cancer.

Authors:  Jacqueline Jonklaas; Mark Danielsen; Hong Wang
Journal:  Thyroid       Date:  2013-07-17       Impact factor: 6.568

5.  Selenium exerts protective effects against oxidative stress and cell damage in human thyrocytes and fibroblasts.

Authors:  Rosaria M Ruggeri; Angela D'Ascola; Teresa M Vicchio; Salvatore Campo; Fiorenza Gianì; Salvatore Giovinazzo; Francesco Frasca; Salvatore Cannavò; Alfredo Campennì; Francesco Trimarchi
Journal:  Endocrine       Date:  2019-12-30       Impact factor: 3.633

Review 6.  Inherited Disorders of Thyroid Hormone Metabolism Defect Caused by the Dysregulation of Selenoprotein Expression.

Authors:  Kyu Won Lee; Yoochan Shin; Sungahn Lee; Sihoon Lee
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-18       Impact factor: 5.555

7.  Selenite Induces Cell Cycle Arrest and Apoptosis via Reactive Oxygen Species-Dependent Inhibition of the AKT/mTOR Pathway in Thyroid Cancer.

Authors:  Zhen Cheng; Shuang Yu; Weiman He; Jie Li; Tianyi Xu; Junyu Xue; Peijie Shi; Shuwei Chen; Yanbing Li; Shubin Hong; Haipeng Xiao
Journal:  Front Oncol       Date:  2021-05-21       Impact factor: 6.244

8.  The role of selenium, vitamin C, and zinc in benign thyroid diseases and of selenium in malignant thyroid diseases: Low selenium levels are found in subacute and silent thyroiditis and in papillary and follicular carcinoma.

Authors:  Roy Moncayo; Alexander Kroiss; Manfred Oberwinkler; Fatih Karakolcu; Matthias Starzinger; Klaus Kapelari; Heribert Talasz; Helga Moncayo
Journal:  BMC Endocr Disord       Date:  2008-01-25       Impact factor: 2.763

9.  Serum Trace Elements Profile in Graves' Disease Patients with or without Orbitopathy in Northeast China.

Authors:  Yongping Liu; Shanshan Liu; Jinyuan Mao; Sichen Piao; Jing Qin; Shiqiao Peng; Xiaochen Xie; Haixia Guan; Yushu Li; Zhongyan Shan; Weiping Teng
Journal:  Biomed Res Int       Date:  2018-01-10       Impact factor: 3.411

Review 10.  Trace Elements in Human Nutrition (II) - An Update.

Authors:  Aliasgharpour Mehri
Journal:  Int J Prev Med       Date:  2020-01-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.